Study of E7389 in Patients With Advanced Solid Tumors
NCT00069264
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
E7389
Sponsor
Eisai Inc.